Literature DB >> 11867645

Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.

Qiang Li1, Hengyi Xiao, Ken-ichi Isobe.   

Abstract

CBP, a protein that binds to cyclic adenosine monophosphate-regulated enhancer-binding protein, and homologue protein, p300, have histone acetyltransferase (HAT) activity and are important in gene transcription, although their physiological functions in vivo remain to be further elucidated. By using immunoprecipitation and HAT activity assay we have found that p300 and CBP have similar tissue patterns of HAT activities, with the highest level in the brain, a relatively high level in the lung, spleen, and heart, an intermediate level in testes and muscle, and a lower level in liver and kidney; that HAT activities of p300 and CBP are relatively stable with advancing age in most examined tissues, but in liver, muscle, and testes, the activities are attenuated with aging; and that HAT activities of p300 and CBP are high in the brain and liver of E14 fetal and newborn mice. These data suggest that the HAT activities of p300 and CBP are important for gene transcription involved in tissue-specific expression, aging, and developing processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867645     DOI: 10.1093/gerona/57.3.b93

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  15 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 2.  Oxidative stress response and Nrf2 signaling in aging.

Authors:  Hongqiao Zhang; Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2015-06-09       Impact factor: 7.376

3.  Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.

Authors:  Janitza L Montalvo-Ortiz; Daniel W Fisher; Guadalupe Rodríguez; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Psychopharmacology (Berl)       Date:  2017-04-18       Impact factor: 4.530

4.  CBP/p300 and associated transcriptional co-activators exhibit distinct expression patterns during murine craniofacial and neural tube development.

Authors:  Vasker Bhattacherjee; Kristin H Horn; Saurabh Singh; Cynthia L Webb; M Michele Pisano; Robert M Greene
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

5.  Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.

Authors:  Ana M M Oliveira; Marcelo A Wood; Conor B McDonough; Ted Abel
Journal:  Learn Mem       Date:  2007-08-29       Impact factor: 2.460

Review 6.  Regulation of heat shock transcription factors and their roles in physiology and disease.

Authors:  Rocio Gomez-Pastor; Eileen T Burchfiel; Dennis J Thiele
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-30       Impact factor: 94.444

7.  Role of cyclic AMP-dependent kinase response element-binding protein in recombinant adeno-associated virus-mediated transduction of heart muscle cells.

Authors:  Jarrod Dean; Jeremy Plante; Gordon S Huggins; Richard O Snyder; Ryuichi Aikawa
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

Review 8.  The heat shock response and small molecule regulators.

Authors:  Margaret K Kurop; Cormac M Huyen; John H Kelly; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2021-09-13       Impact factor: 6.514

9.  Immunohistochemical localization of cyclic AMP-responsive element binding protein (CREB)-binding protein in the pig retina during postnatal development.

Authors:  Hanseul Oh; Heechul Kim; Meejung Ahn; Chanwoo Jeong; Jinwoo Jeong; Changjong Moon; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2011-06-30

Review 10.  ANRIL: molecular mechanisms and implications in human health.

Authors:  Ada Congrains; Kei Kamide; Mitsuru Ohishi; Hiromi Rakugi
Journal:  Int J Mol Sci       Date:  2013-01-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.